Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 2,024,000 | 2,046,000 | 2,152,000 | 2,048,000 | 2,071,000 |
| Cost of Goods | 604,000 | 580,000 | 636,000 | 575,000 | 563,000 |
| Gross Profit | 1,420,000 | 1,466,000 | 1,516,000 | 1,473,000 | 1,508,000 |
| Operating Expenses | 1,117,000 | 886,000 | 1,945,000 | 1,620,000 | 1,228,000 |
| Operating Income | 303,000 | 580,000 | -429,000 | -147,000 | 280,000 |
| Interest Expense | 118,000 | 131,000 | 136,000 | 147,000 | 146,000 |
| Other Income | -85,000 | 13,000 | -30,000 | 35,000 | -8,000 |
| Pre-tax Income | 100,000 | 462,000 | -595,000 | -259,000 | 126,000 |
| Income Tax | 2,000 | 140,000 | -137,000 | 13,000 | 11,000 |
| Net Income Continuous | 98,000 | 322,000 | -458,000 | -272,000 | 115,000 |
| Net Income | $98,000 | $322,000 | $-458,000 | $-272,000 | $115,000 |
| EPS Basic Total Ops | 0.07 | 0.22 | -0.31 | -0.18 | 0.08 |
| EPS Basic Continuous Ops | 0.07 | 0.22 | -0.31 | -0.18 | 0.08 |
| EPS Diluted Total Ops | 0.07 | 0.21 | -0.31 | -0.18 | 0.08 |
| EPS Diluted Continuous Ops | 0.07 | 0.21 | -0.31 | -0.18 | 0.08 |
| EBITDA(a) | $303,000 | $580,000 | $-429,000 | $-147,000 | $280,000 |